Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Zi-Ying
Contact Zi-Ying, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck RackActions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Articles
CXCL9 as an effective biomarker of immunotherapy efficacy
Back to Journals » Journal of Hepatocellular Carcinoma » Volume 11 Authors Wang P, Xu MH, Xu WX, Dong ZY, Shen YH , Qin WZ Received 30 November 2023 Accepted for publication 18 February 2024 Published 8 May 2024 Volume 2024:11 Pages 787—800 DOI https://doi.org/10.2147/JHC.S450468 Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 2 Editor who approved publication: Prof.
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Zi-Ying
Contact Zi-Ying, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack